1-4 of 4
Heng-Xiang Wang
Close
Sort by
Journal Articles

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

Lung-Ji Chang, PhD, Lujia Dong, MD, Yu-Chen Liu, MSc, Shih-Ting Tsao, MSc, Ya-Chen Li, PhD, Li Liu, MD, Zhiyong Gao, MD, Xiyou Tan, MD, Dao-Pei Lu, MD, Jian-Ping Zhang, Jing-Bo Wang, Yu-Ming Ying, MD, Le-Ping Zhang, MD, Huyong Zheng, MD PhD, Kai Wang, MD PhD, Xiao-Li Zheng, MD, Heng-Xiang Wang, MD, Xun Lai, MD, Dong Li, MD
Journal: Blood
Blood (2016) 128 (22): 587.
https://doi.org/10.1182/blood.V128.22.587.587
Published: 2016
Journal Articles

Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China

Lujia Dong, MD, Lung-Ji Chang, PhD, Zhiyong Gao, MD, Dao-Pei Lu, MD, Jian-Ping Zhang, MD, Jing-Bo Wang, MD, Le-Ping Zhang, MD, Yu-Hong Chen, MD, Hu-Yong Zheng, MD, Ting Liu, Ting Niu, MD PhD, He Huang, MD PhD, Rong Liu, MD, Heng-Xiang Wang, MD, Li Gao, MD, Tong-Hua Yang, MD, Xun Lai, MD
Journal: Blood
Blood (2015) 126 (23): 3774.
https://doi.org/10.1182/blood.V126.23.3774.3774
Published: 2015
Journal Articles

A Experimental Study and Clinical Result of Prophylaxis aGVHD with Humanized Anti-CD25 Monoclonal Antibody in Haploidentical BMT.

Shu-Quan Ji, MD, Hui-Ren Chen, MD, Heng-Xiang Wang, Hong-Min Yan, Mei Xue, Jing Liu, Chang-Q.(Micky) Xun, MD
Journal: Blood
Blood (2004) 104 (11): 1251.
https://doi.org/10.1182/blood.V104.11.1251.1251
Published: 2004
Journal Articles

Haploidentical Bone Marrow Transplantation for Treatment of Patients with Aggressive and Refractory Lymphoma.

Hui-Ren Chen, MD, Shu-Quan Ji, MD, Heng-Xiang Wang, Hong-Min Yan, Mei Xue, Jing Liu, Chang-Q.(Micky) Xun, MD
Journal: Blood
Blood (2004) 104 (11): 5159.
https://doi.org/10.1182/blood.V104.11.5159.5159
Published: 2004